GlassScriptPhysician profile
Mohammed A Khan
NPI 1093794661
$1,562.37
in general payments reported to CMS, 2019-2025
16 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,017 · 2020: $54.50 · 2021: $235 · 2023: $71.30 · 2024: $21.33 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $200.29 | 2019-2024 | |
| Amgen INC. | $161.66 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $150.44 | 2019 | |
| Bardy Diagnostics, INC. | $146.34 | 2021 | |
| Abbott Laboratories | $146.29 | 2019 | |
| Janssen Pharmaceuticals, INC | $131.62 | 2019 | |
| Beone Medicines USA, INC. | $126.50 | 2025 | Brukinsa |
| Irhythm Technologies, INC. | $111.56 | 2019-2023 | Zio Monitor, Zio Xt Patch |
| Pfizer INC. | $83.51 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.77 | 2019-2021 | |
| Lundbeck LLC | $63.28 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $45.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.90 | 2019-2020 | |
| Heartflow, INC. | $36.54 | 2025 | |
| Philips North America LLC | $19.89 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ekos Corporation | $14.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.